Dexamethasone suppression tests in liver cirrhosis - abnormalities in patients with primary hepatocellular carcinoma.
Akanji, A.O., Ola, S.O., Malabu, U.H., Oduwole, O.O., and Olubuyide, I.O. (1995) Dexamethasone suppression tests in liver cirrhosis - abnormalities in patients with primary hepatocellular carcinoma. Medical Science Research, 23. pp. 781-782.
PDF (Published Version)
- Published Version
Restricted to Repository staff only |
Abstract
[Extract] Primary hepatocellular carcinoma (PHC), an important cause of morbidity and mortality in many African and Asian countries [1-4], has protean manifestations. Aside from its classical clinical and biochemical presentation, PHC is associated with a variety of paraneoplastic phenomena, including increased erythropoietin production, hypoglycaemia, hypercholesterolaemia and hypercalcaemia [5,6]. The terminal patient with PHC in Nigeria may have a variety of fluid and electrolyte abnormalities, particularly resistant ascites and hypokalaemia.
Item ID: | 23507 |
---|---|
Item Type: | Article (Research - C1) |
ISSN: | 0269-8951 |
Keywords: | cortisol, dexamethasone supression tests, liver diseases, hepatoma, hepatocellular carcinoma |
Date Deposited: | 03 Jan 2013 23:00 |
FoR Codes: | 11 MEDICAL AND HEALTH SCIENCES > 1103 Clinical Sciences > 110306 Endocrinology @ 100% |
SEO Codes: | 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920106 Endocrine Organs and Diseases (excl. Diabetes) @ 100% |
Downloads: |
Total: 2 |
More Statistics |